Skip to content

Retroperıtoneal Soft-Tıssue Sarcomas

Retroperıtoneal Soft-Tıssue Sarcomas: Retrospectıve Clınıcal Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05044624
Enrollment
18
Registered
2021-09-16
Start date
2016-03-01
Completion date
2021-06-01
Last updated
2021-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Margin, Tumor-Free, Retroperitoneal Sarcoma

Keywords

Soft tissue sarcoma, Surgery, Multidisciplinary Sarcoma Team

Brief summary

: Soft Tissue Sarcomas are rare mesenchymal tumors with many subtypes. Clean margin-wide resection is recommended for treatment. The guidelines recommend that sarcoma treatments be carried out in sarcoma centers. In this study, the location, histopathological features, clinical and demographic features, recurrence, and prognosis of retroperitoneal sarcomas were investigated.

Detailed description

The demographic, histopathological, and immunohistochemical data of the patients who were operated on with the diagnosis of intraabdominal mass at Istanbul Medeniyet University Göztepe Prof. Dr. Süleyman Yalçın City Hospital from March 2016 to December 2020 were retrospectively evaluated. Ethical approval was obtained from Istanbul Medeniyet University Göztepe Prof. Dr. Süleyman Yalçın City Hospital Ethics Committee. Patients diagnosed with pathological sarcoma subclass were included in the study. Patients younger than 18 years were excluded from the study. Visceral organ-origin sarcomas and extremity sarcomas were also excluded from the study. GIST's were included in sarcoma subtypes by WHO in 2013. However, they were not included in the study due to their solid organ origin. The data of 18 patients' whore remained after the exclusion criteria were analyzed retrospectively. Pathology samples of the patients were re-examined by a single pathologist. The demographic analysis was used for statistics.

Interventions

PROCEDUREretroperitoneal mass excision

retroperitoneal mass excision

Sponsors

Istanbul Medeniyet University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients operated with the diagnosis of intra-abdominal mass * patients diagnosed with pathological sarcoma subclasses

Exclusion criteria

* Patients younger than 18 years * Visceral organ-origin sarcomas * extremity sarcomas * GIST

Design outcomes

Primary

MeasureTime frameDescription
Clean margin wide resection63 montheffect of clean surgical margin on recurrence

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026